{"rows":[{"id":5293,"title":"Characterization of challenging experiences (i.e., bad trips) after ingesting psilocybin","authors":"Matthew P. Bradstreet, Matthew W. Johnson, Katherine A. MacLean, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2014-06-07","publication_year":2014,"doi":"10.1016/j.drugalcdep.2014.02.072","pubmed_id":null,"openalex_id":"https://openalex.org/W1998044228","source_url":"https://doi.org/10.1016/j.drugalcdep.2014.02.072","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2014.02.072","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2014.02.072","source_url":"https://doi.org/10.1016/j.drugalcdep.2014.02.072","doi":"10.1016/j.drugalcdep.2014.02.072","pmid":"","publication_date":"2014-06-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5292,"title":"Examining the psychological mechanisms of psilocybin-assisted smoking cessation treatment: A pilot study","authors":"Albert Garcia-Romeu, Matthew W. Johnson, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2014-06-07","publication_year":2014,"doi":"10.1016/j.drugalcdep.2014.02.200","pubmed_id":null,"openalex_id":"https://openalex.org/W2111139037","source_url":"https://doi.org/10.1016/j.drugalcdep.2014.02.200","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2014.02.200","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2014.02.200","source_url":"https://doi.org/10.1016/j.drugalcdep.2014.02.200","doi":"10.1016/j.drugalcdep.2014.02.200","pmid":"","publication_date":"2014-06-07","importer_version":"2.1.3","text_redistributed":false}},{"id":5282,"title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenology","authors":"Theresa M. Carbonaro, Frederick S. Barrett, Matthew P. Bradstreet, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2014-12-16","publication_year":2014,"doi":"10.1016/j.drugalcdep.2014.09.118","pubmed_id":null,"openalex_id":"https://openalex.org/W2317303115","source_url":"https://doi.org/10.1016/j.drugalcdep.2014.09.118","substance_tags":"psilocybin","topic_tags":"Pharmacology,Observational Study,Toxicity","study_type":"Observational Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2014.09.118","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2014.09.118","source_url":"https://doi.org/10.1016/j.drugalcdep.2014.09.118","doi":"10.1016/j.drugalcdep.2014.09.118","pmid":"","publication_date":"2014-12-16","importer_version":"2.1.3","text_redistributed":false}},{"id":5281,"title":"The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin","authors":"Frederick S. Barrett, Matthew P. Bradstreet, Jeannie-Marie Leoutsakos, Matthew W. Johnson, Katherine A. MacLean, Robert L. Jesse, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2014-12-16","publication_year":2014,"doi":"10.1016/j.drugalcdep.2014.09.060","pubmed_id":null,"openalex_id":"https://openalex.org/W2326208220","source_url":"https://doi.org/10.1016/j.drugalcdep.2014.09.060","substance_tags":"psilocybin","topic_tags":"Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:04","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2014.09.060","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2014.09.060","source_url":"https://doi.org/10.1016/j.drugalcdep.2014.09.060","doi":"10.1016/j.drugalcdep.2014.09.060","pmid":"","publication_date":"2014-12-16","importer_version":"2.1.3","text_redistributed":false}},{"id":5260,"title":"Comparative phenomenology of psilocybin experiences in research and non-research settings","authors":"Theresa M. Carbonaro, Margaret A. Klinedinst, Matthew W. Johnson, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2015-10-31","publication_year":2015,"doi":"10.1016/j.drugalcdep.2015.07.1017","pubmed_id":null,"openalex_id":"https://openalex.org/W2346012242","source_url":"https://doi.org/10.1016/j.drugalcdep.2015.07.1017","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:03","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2015.07.1017","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2015.07.1017","source_url":"https://doi.org/10.1016/j.drugalcdep.2015.07.1017","doi":"10.1016/j.drugalcdep.2015.07.1017","pmid":"","publication_date":"2015-10-31","importer_version":"2.1.3","text_redistributed":false}},{"id":5258,"title":"Long-term follow-up of psilocybin-facilitated smoking cessation: Abstinence outcomes and qualitative analysis of participant accounts","authors":"Albert Garcia-Romeu, Tehseen Noorani, Roland R. Griffiths, Matthew W. Johnson","journal":"Drug and Alcohol Dependence","publication_date":"2015-11-01","publication_year":2015,"doi":"10.1016/j.drugalcdep.2015.07.1130","pubmed_id":null,"openalex_id":"https://openalex.org/W2470759954","source_url":"https://doi.org/10.1016/j.drugalcdep.2015.07.1130","substance_tags":"psilocybin","topic_tags":"Addiction,Receptor Pharmacology","study_type":"Qualitative Study","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:03","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2015.07.1130","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2015.07.1130","source_url":"https://doi.org/10.1016/j.drugalcdep.2015.07.1130","doi":"10.1016/j.drugalcdep.2015.07.1130","pmid":"","publication_date":"2015-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5257,"title":"Validation of the revised mystical experiences questionnaire in experimental sessions with psilocybin","authors":"Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2015-11-01","publication_year":2015,"doi":"10.1016/j.drugalcdep.2015.07.961","pubmed_id":null,"openalex_id":"https://openalex.org/W2218541786","source_url":"https://doi.org/10.1016/j.drugalcdep.2015.07.961","substance_tags":"psilocybin","topic_tags":"Mystical Experience","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:03","last_checked":"2026-08-09 08:25:53","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2015.07.961","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2015.07.961","source_url":"https://doi.org/10.1016/j.drugalcdep.2015.07.961","doi":"10.1016/j.drugalcdep.2015.07.961","pmid":"","publication_date":"2015-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5212,"title":"Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and non-research settings","authors":"Theresa M. Carbonaro, Matthew W. Johnson, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2017-01-21","publication_year":2017,"doi":"10.1016/j.drugalcdep.2016.08.107","pubmed_id":null,"openalex_id":"https://openalex.org/W2578015169","source_url":"https://doi.org/10.1016/j.drugalcdep.2016.08.107","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:03","last_checked":"2026-08-09 08:25:52","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2016.08.107","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2016.08.107","source_url":"https://doi.org/10.1016/j.drugalcdep.2016.08.107","doi":"10.1016/j.drugalcdep.2016.08.107","pmid":"","publication_date":"2017-01-21","importer_version":"2.1.3","text_redistributed":false}},{"id":5211,"title":"Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience","authors":"Frederick S. Barrett, Matthew W. Johnson, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2017-01-21","publication_year":2017,"doi":"10.1016/j.drugalcdep.2016.08.058","pubmed_id":null,"openalex_id":"https://openalex.org/W2577870460","source_url":"https://doi.org/10.1016/j.drugalcdep.2016.08.058","substance_tags":"psilocybin","topic_tags":"Addiction,Default Mode Network,Randomized Controlled Trial","study_type":"Randomized Controlled Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:03","last_checked":"2026-08-09 08:25:52","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2016.08.058","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2016.08.058","source_url":"https://doi.org/10.1016/j.drugalcdep.2016.08.058","doi":"10.1016/j.drugalcdep.2016.08.058","pmid":"","publication_date":"2017-01-21","importer_version":"2.1.3","text_redistributed":false}},{"id":4600,"title":"Regional Differences of Self-Reported Past-12-month Marijuana, Psilocybin, and Cocaine Use: Results From NDEWS Rapid Street Reporting 2021-2022","authors":"Nae Won, Anna Wang, Joseph J. Palamar, Nicole D. Fitzgerald, MeLisa R. Creamer, Catherine W. Striley, Linda B. Cottler","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110222","pubmed_id":null,"openalex_id":"https://openalex.org/W4400600406","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110222","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110222","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110222","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110222","doi":"10.1016/j.drugalcdep.2023.110222","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4599,"title":"Prevalence of Psilocybin and Cannabis Concurrent Use During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study","authors":"Denise C. Vidot, Amrit Baral, Bria-Necole Diggs, Sitara M. Weerakoon, Moudou Baquai, Ramessu Iyi, Michelle Weiner, Sarah Messiah","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110578","pubmed_id":null,"openalex_id":"https://openalex.org/W4400599881","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110578","substance_tags":"psilocybin","topic_tags":"Spirituality","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110578","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110578","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110578","doi":"10.1016/j.drugalcdep.2023.110578","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4598,"title":"SPONTANEOUS CHANGES IN CIGARETTE SMOKING FOLLOWING PSILOCYBIN-ASSISTED TREATMENT FOR ALCOHOL USE DISORDER","authors":"Broc A. Pagni, Noah D. Gold, Michael P. Bogenschutz","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110063","pubmed_id":null,"openalex_id":"https://openalex.org/W4400575547","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110063","substance_tags":"psilocybin","topic_tags":"Addiction","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110063","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110063","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110063","doi":"10.1016/j.drugalcdep.2023.110063","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4597,"title":"High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health Study","authors":"Denise C. Vidot, Bria-Necole Diggs, Amrit Baral, Michaela E. Larson, Sitara M. Weerakoon, Moudou Baquai, Ramessu Iyi, Michelle Weiner, Marlene Camacho-Rivera, Sarah Messiah","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110575","pubmed_id":null,"openalex_id":"https://openalex.org/W4400575520","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110575","substance_tags":"psilocybin","topic_tags":"Addiction,Spirituality","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110575","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110575","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110575","doi":"10.1016/j.drugalcdep.2023.110575","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4596,"title":"Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin Therapy","authors":"Alan K. Davis, Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Frederick S. Barrett, Roland R. Griffiths","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110609","pubmed_id":null,"openalex_id":"https://openalex.org/W4400575216","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110609","substance_tags":"psilocybin","topic_tags":"Anxiety","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110609","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110609","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110609","doi":"10.1016/j.drugalcdep.2023.110609","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4595,"title":"Physiological Effects of Psilocybin, Psilacetin, and DOI in Rats","authors":"Shelby A. McGriff, Grant C. Glatfelter, David R. Manke, A.R. Chadeayne, Charles W. Schindler, Michaël Baumann","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110445","pubmed_id":null,"openalex_id":"https://openalex.org/W4400574686","source_url":"http://dx.doi.org/10.1016/j.drugalcdep.2023.110445","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110445","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110445","source_url":"http://dx.doi.org/10.1016/j.drugalcdep.2023.110445","doi":"10.1016/j.drugalcdep.2023.110445","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4594,"title":"Lifetime Depression and Psilocybin Mushroom Use in U.S. Adults, 2008-2019","authors":"Lauren Gorfinkel, Julia M. Bujno, Claire Walsh, Dvora Shmulewitz, Deborah S. Hasin","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110267","pubmed_id":null,"openalex_id":"https://openalex.org/W4400574683","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110267","substance_tags":"psilocybin","topic_tags":"Depression","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110267","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110267","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110267","doi":"10.1016/j.drugalcdep.2023.110267","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4593,"title":"Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse Indications","authors":"Ryan K. Lanier, Michael P. Bogenschutz, Emmanuelle A. D. Schindler, Benjamin Kelmendi, Caitlyn Durgin, Judy Ashworth","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110862","pubmed_id":null,"openalex_id":"https://openalex.org/W4400574532","source_url":"http://dx.doi.org/10.1016/j.drugalcdep.2023.110862","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110862","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110862","source_url":"http://dx.doi.org/10.1016/j.drugalcdep.2023.110862","doi":"10.1016/j.drugalcdep.2023.110862","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4592,"title":"Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or Psilocybin","authors":"Rafael Lancelotta, Christopher Timmerman, Ana María Ortiz Bernal, Sandeep M. Nayak, Nathan D. Sepeda, Aki Nikolaidis, Roland R. Griffiths, Alan K. Davis","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110861","pubmed_id":null,"openalex_id":"https://openalex.org/W4400574241","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110861","substance_tags":"psilocybin","topic_tags":"Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:43","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110861","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110861","source_url":"https://doi.org/10.1016/j.drugalcdep.2023.110861","doi":"10.1016/j.drugalcdep.2023.110861","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4591,"title":"Developing Core Consensus Measures for Assessment of Psilocybin Services","authors":"P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, David Morgan, Sarann Bielavitz, Dennis McCarty, Christopher S. Stauffer","journal":"Drug and Alcohol Dependence","publication_date":"2024-07-01","publication_year":2024,"doi":"10.1016/j.drugalcdep.2023.110268","pubmed_id":null,"openalex_id":"https://openalex.org/W4400575107","source_url":"http://dx.doi.org/10.1016/j.drugalcdep.2023.110268","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:42","last_checked":"2026-08-09 08:25:28","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2023.110268","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2023.110268","source_url":"http://dx.doi.org/10.1016/j.drugalcdep.2023.110268","doi":"10.1016/j.drugalcdep.2023.110268","pmid":"","publication_date":"2024-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4452,"title":"Clinical Trial Comparing Psilocybin to Nicotine Patch for Tobacco Addiction","authors":"Matthew Weirick Johnson","journal":"Drug and Alcohol Dependence","publication_date":"2025-02-01","publication_year":2025,"doi":"10.1016/j.drugalcdep.2024.112187","pubmed_id":null,"openalex_id":"https://openalex.org/W4407077022","source_url":"https://doi.org/10.1016/j.drugalcdep.2024.112187","substance_tags":"psilocybin","topic_tags":"Addiction,Clinical Trial","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:34:41","last_checked":"2026-08-09 08:25:23","bibtex":null,"source_record_id":"DOI:10.1016/j.drugalcdep.2024.112187","abstract_available":false,"abstract_source":null,"abstract_source_url":null,"abstract_redistributed":false,"text_rights_status":"not_applicable_no_text","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.drugalcdep.2024.112187","source_url":"https://doi.org/10.1016/j.drugalcdep.2024.112187","doi":"10.1016/j.drugalcdep.2024.112187","pmid":"","publication_date":"2025-02-01","importer_version":"2.1.3","text_redistributed":false}}],"total":26,"page":1,"per_page":20,"pages":2,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Drug and Alcohol Dependence","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}